Literature DB >> 18726828

Deconvolution of insulin secretion, insulin hepatic extraction post-hepatic delivery rates and sensitivity during 24-hour standardized meals: time course of glucose homeostasis in leptin replacement treatment.

V P Andreev1, G Paz-Filho, M-L Wong, J Licinio.   

Abstract

Minimally invasive methodology, mathematical model, and software for analysis of glucose homeostasis by deconvolution of insulin secretion, hepatic extraction, post-hepatic delivery, and sensitivity from 24-hour standardized meals test have been developed and illustrated by the study of glucose homeostasis of a genetically based leptin-deficient patient before and after leptin replacement treatment. The only genetically leptin-deficient adult man identified in the world was treated for 24 months with recombinant methionyl human leptin. Blood was collected every 7 minutes for 24 hours, with standardized meals consumed during the 4 visits: at baseline, one-week, 18-months, and 24-months after initiation of the treatment. Concentrations of insulin, C-peptide, and plasma glucose were measured. Insulin secretion was obtained by deconvolution of C-peptide data. Hepatic insulin extraction was determined based on our modifications of the insulin kinetics model . Insulin sensitivity for each of the four meals was calculated by using the minimal glucose model approach. Hepatic extraction of insulin was the first element of glucose homeostasis to respond to leptin replacement treatment and increased 2-fold after one week of treatment. Insulin secretion and delivery rates decreased more than 2-fold and insulin sensitivity increased 10-fold after 24 months of treatment. Computer programs for analysis of 24-hour insulin secretion, extraction, delivery, and action are available upon request.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726828     DOI: 10.1055/s-0028-1082048

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  13 in total

1.  Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?

Authors:  Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2009-04       Impact factor: 5.958

2.  Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.

Authors:  Gilberto Paz-Filho; Claudio Mastronardi; Tuncay Delibasi; Ma-Li Wong; Julio Licinio
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-11

Review 3.  The role of leptin in obesity and the potential for leptin replacement therapy.

Authors:  Helin Feng; Lihua Zheng; Zhangying Feng; Yaheng Zhao; Ning Zhang
Journal:  Endocrine       Date:  2012-12-29       Impact factor: 3.633

4.  Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.

Authors:  Gilberto Paz-Filho; Karin Esposito; Barry Hurwitz; Anil Sharma; Chuanhui Dong; Victor Andreev; Tuncay Delibasi; Halil Erol; Alejandro Ayala; Ma-Li Wong; Julio Licinio
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

5.  Mouse Embryonic Fibroblasts Protect ob/ob Mice From Obesity and Metabolic Complications.

Authors:  Daniel Ferguson; Mitchell Blenden; Irina Hutson; Yingqiu Du; Charles A Harris
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

6.  Effects of leptin deficiency and replacement on cerebellar response to food-related cues.

Authors:  Steven M Berman; Gilberto Paz-Filho; Ma-Li Wong; Milky Kohno; Julio Licinio; Edythe D London
Journal:  Cerebellum       Date:  2013-02       Impact factor: 3.847

7.  Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.

Authors:  Qi Sun; Rob M van Dam; James B Meigs; Oscar H Franco; Christos S Mantzoros; Frank B Hu
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

Review 8.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871

9.  Benefits of leptin therapy in HIV patients.

Authors:  Uma Sinha; Keshab Sinharay; Nilanjan Sengupta; Prasanta Mukhopadhyay
Journal:  Indian J Endocrinol Metab       Date:  2012-12

10.  Leptin therapy, insulin sensitivity, and glucose homeostasis.

Authors:  Gilberto Paz-Filho; Claudio Mastronardi; Ma-Li Wong; Julio Licinio
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.